О группе

This group is run by Dr Anthony Melvin Crasto, Glenmark scientist helping millions, already million hits on google. this is for interactions in organic chemistry
DR ANTHONY MELVIN CRASTO, Worlddrugtracker, Born in Mumbai in 1964 and graduated from Mumbai University, Completed his PhD from ICT ,1991, Mumbai, India, in Organic chemistry, The thesis topic was Synthesis of Novel Pyrethroid Analogues, Currently he is working with GLENMARK- GENERICS LTD, Research centre as Principal Scientist, Process Research (bulk actives) at Mahape, Navi Mumbai, India. Prior to joining Glenmark, he worked with major multinationals like Hoechst Marion Roussel, now sSanofi, Searle India ltd, now Rpg lifesciences, etc. he is now helping millions, has million hits on google on all organic chemistry websites. His New Drug Approvals, Green Chemistry International, Eurekamoments in organic chemistry are some most read blogs He has hands on experience in initiation and developing novel routes for drug molecules and implementation them on commercial scale over a 25 year tenure, good knowledge of IPM, GMP, Regulatory aspects, he has several international drug patents published worldwide. He gas good proficiency in Technology transfer, Spectroscopy, Stereochemistry, Synthesis, polymorphism etc He suffered a paralytic stroke in dec 2007 and is bound to a wheelchair, this seems to have injected feul in him to help chemists around the world, he is more active than before and is pushing boundaries, he has one lakh connections on all networking sites, He makes himself available to all, contact him on +91 9323115463, amcrasto@gmail.com

Обсуждения

Sitafloxacin
http://newdrugapprovals.org/2014/03/30/sitafloxacin-antibacterial-dna-gyrase-inhibitor/
0 комментариев
добавлено Anthony Crasto мар 30, 2014
TACROLIMUS
http://newdrugapprovals.org/2014/03/11/tacrolimus/
0 комментариев
добавлено Anthony Crasto мар 11, 2014
FDA DRUG APPROVAL PROCESS
http://newdrugapprovals.org/2014/02/28/the-fdas-drug-review-process-ensuring-drugs-are-safe-and-effective/
0 комментариев
добавлено Anthony Crasto мар 1, 2014
Cangrelor
http://newdrugapprovals.org/2013/03/13/cangrelor-ar-c69931mx-shows-improvement-over-plavix-in-phase-iii-trial/
0 комментариев
добавлено Anthony Crasto фев 24, 2014
Sonidegib/Erismodegib..Novartis Cancer Drug LDE225 Meets Primary Endpoint in Phase 2
newdrugapprovals.org/2014/02/20/sonidegiberismodegib-novartis-cancer-drug-lde225-meets-primary-endpoint-in-phase-2/
0 комментариев
добавлено Anthony Crasto фев 20, 2014
The US FDA has issued full approval for Israeli drugmaker Teva’s Synribo (omacetaxine mepesuccinate)高三尖杉酯碱 for chronic myeloid...
http://newdrugapprovals.org/2014/02/18/the-us-fda-has-issued-full-approval-for-israeli-drugmaker-tevas-synribo-omacetaxine-mepesuccinate-for-chronic-myeloid-leukaemia-cml/
0 комментариев
добавлено Anthony Crasto фев 18, 2014
TRIPHOSGENE HANDLING
http://newdrugapprovals.org/2014/02/14/a-review-and-methods-to-handle-phosgene-triphosgene-safely-during-drug-synthesis/
0 комментариев
добавлено Anthony Crasto фев 14, 2014
FEMALE VIAGRA
http://newdrugapprovals.org/2014/02/13/female-viagra-flibanserin-now-on-track-for-q3-filing-in-usa/
0 комментариев
добавлено Anthony Crasto фев 13, 2014
ORGANIC SPECTROSCOPY INTERNATIONA;L
http://orgspectroscopyint.blogspot.in/
0 комментариев
добавлено Anthony Crasto фев 9, 2014
ORGANIC SPECTROSCOPY INTERNATIONA;L
http://orgspectroscopyint.blogspot.in/
0 комментариев
добавлено Anthony Crasto фев 9, 2014